A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 18, 2014

Primary Completion Date

November 29, 2014

Study Completion Date

November 29, 2014

Conditions

Symptomatic Anemia

Interventions

DRUG

DA3880

DRUG

Aranesp

Trial Locations (1)

PRA, Zuidlaren

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02241200 - A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen) | Biotech Hunter | Biotech Hunter